Perineal reconstruction for advanced pelvic malignancies

• by Zoe Li, Alethea Tang, Peter Drew

• August 19, 2025

H2-blocker tachyphylaxis may limit LPR therapy

Acid suppression wanes rapidly with repeated dosing, supporting intermittent use and phenotype-directed evaluation of persistent symptoms.

• by Andrea Surnit

• October 23, 2026

• 4 min

Claims-Based Body Mass Index and Obesity Comparative Effectiveness Research—Weighing the Evidence

• by Karan R. Chhabra, Babak J. Orandi

• October 27, 2026

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

• October 15, 2026

• 1 min